Sterling Capital Management LLC Mirum Pharmaceuticals, Inc. Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Sterling Capital Management LLC holds 40 shares of MIRM stock, worth $1,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40Holding current value
$1,756% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding MIRM
# of Institutions
188Shares Held
53.9MCall Options Held
177KPut Options Held
80.3K-
Frazier Life Sciences Management, L.P. Menlo Park, CA6.5MShares$285 Million13.09% of portfolio
-
Janus Henderson Group PLC London, X04.48MShares$197 Million0.09% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.45MShares$151 Million2.37% of portfolio
-
Black Rock Inc. New York, NY3.24MShares$142 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.08MShares$135 Million3.81% of portfolio
About Mirum Pharmaceuticals, Inc.
- Ticker MIRM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,751,700
- Market Cap $1.61B
- Description
- Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...